1. Home
  2. CEE vs OKYO Comparison

CEE vs OKYO Comparison

Compare CEE & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CEE
  • OKYO
  • Stock Information
  • Founded
  • CEE 1990
  • OKYO 2007
  • Country
  • CEE Germany
  • OKYO United Kingdom
  • Employees
  • CEE N/A
  • OKYO N/A
  • Industry
  • CEE Finance Companies
  • OKYO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CEE Finance
  • OKYO Health Care
  • Exchange
  • CEE Nasdaq
  • OKYO Nasdaq
  • Market Cap
  • CEE 105.5M
  • OKYO 85.0M
  • IPO Year
  • CEE N/A
  • OKYO 2022
  • Fundamental
  • Price
  • CEE $15.70
  • OKYO $2.10
  • Analyst Decision
  • CEE
  • OKYO Strong Buy
  • Analyst Count
  • CEE 0
  • OKYO 1
  • Target Price
  • CEE N/A
  • OKYO $7.00
  • AVG Volume (30 Days)
  • CEE 22.0K
  • OKYO 56.1K
  • Earning Date
  • CEE 01-01-0001
  • OKYO 07-18-2025
  • Dividend Yield
  • CEE 3.86%
  • OKYO N/A
  • EPS Growth
  • CEE N/A
  • OKYO N/A
  • EPS
  • CEE N/A
  • OKYO N/A
  • Revenue
  • CEE N/A
  • OKYO N/A
  • Revenue This Year
  • CEE N/A
  • OKYO N/A
  • Revenue Next Year
  • CEE N/A
  • OKYO N/A
  • P/E Ratio
  • CEE N/A
  • OKYO N/A
  • Revenue Growth
  • CEE N/A
  • OKYO N/A
  • 52 Week Low
  • CEE $7.80
  • OKYO $0.90
  • 52 Week High
  • CEE $10.32
  • OKYO $3.35
  • Technical
  • Relative Strength Index (RSI)
  • CEE 41.35
  • OKYO 34.65
  • Support Level
  • CEE $15.60
  • OKYO $2.06
  • Resistance Level
  • CEE $16.33
  • OKYO $2.17
  • Average True Range (ATR)
  • CEE 0.44
  • OKYO 0.14
  • MACD
  • CEE -0.06
  • OKYO -0.00
  • Stochastic Oscillator
  • CEE 49.36
  • OKYO 10.00

About CEE The Central and Eastern Europe Fund Inc. (The)

CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: